Monitoring and Mitigating Adverse Events

Exploring general principles and practices for monitoring and mitigating adverse events in patients with chronic GvHD treated with systemic agents, and determining when dose modification or treatment discontinuation is warranted.

EP: 1.Treatment Goals and Options for Chronic GvHD

EP: 2.Appropriateness of Initial Therapy for Chronic GvHD

EP: 3.Efficacy and Safety of Emerging Therapies

EP: 4.Safety Concerns with Ruxolitinib

Now Viewing

EP: 5.Monitoring and Mitigating Adverse Events

EP: 6.Quality of Life Impact

EP: 7.Axatilimab Trial Results

EP: 8.Future Landscape of cGvHD Management

Related Videos